Dr. Alex Zhavoronkov, Founder and CEO of Insilico Medicine, has been invited to speak at the Nature conference: Redefining Healthcare in the Age of AI in Paris on September 8 at 16:30. (IMAGE)

InSilico Medicine

Dr. Alex Zhavoronkov, Founder and CEO of Insilico Medicine, has been invited to speak at the Nature conference: Redefining Healthcare in the Age of AI in Paris on September 8 at 16:30.

Caption

He will deliver a presentation titled "Six Aging Clocks Confirmed Biological Age Reversal in Phase IIa Trial of a Novel Therapeutic Discovered Using Aging Research and Generative AI". As a trailblazer in AI drug discovery and health tech, he will elaborate on this high-profile Phase IIa clinical trial, where the research team utilized generative AI and longevity science to discover novel therapeutics. He will highlight how six distinct aging clocks rigorously confirmed biological age reversal in humans for the first time—marking a groundbreaking milestone in anti-aging drug development

Credit

Insilico Medicine

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.